FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Bernhard Peskar

Research Profile

Chemicals & Drugs

Living Beings

Anatomy

Procedures

Radioimmunoassay

Physiology

Platelet Aggregation

Co-author Network

Publications

TOP 3
Viktoria Konya; Gunther Marsche; Gerald P Parzmair; Bernhard A Peskar; Sonia Philipose; Wolfgang Sattler; Rufina Schuligoi; Anna Theiler; Andreas Üllen; Nora Kampitsch; Akos Heinemann
Endothelial E-type prostanoid 4 receptors promote barrier function and inhibit neutrophil trafficking.
Sonia Philipose; Sasa Frank; Akos Heinemann; Viktoria Konya; Mirjana Lazarevic; Gunther Marsche; Lisa M Pasterk; Bernhard A Peskar; Rufina Schuligoi
Laropiprant attenuates EP3 and TP prostanoid receptor-mediated thrombus formation.
Petra Luschnig-Schratl; Gunther Marsche; Bernhard A Peskar; Sonia Philipose; Claudia Samberger; Rufina Schuligoi; Eva M Sturm; Eleonore Fröhlich; Stefan Gattenlöhner; Viktoria Konya; Doris Lang-Loidolt; Irmgard Th Lippe; Akos Heinemann
EP4 receptor stimulation down-regulates human eosinophil function.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Bernhard Peskar (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Viktoria Konya; Gunther Marsche; Gerald P Parzmair; Bernhard A Peskar; Sonia Philipose; Wolfgang Sattler; Rufina Schuligoi; Anna Theiler; Andreas Üllen; Nora Kampitsch; Akos Heinemann
Endothelial E-type prostanoid 4 receptors promote barrier function and inhibit neutrophil trafficking.
The Journal of allergy and clinical immunology 2013;131(2):532-40.e1-2.
2012: Sonia Philipose; Sasa Frank; Akos Heinemann; Viktoria Konya; Mirjana Lazarevic; Gunther Marsche; Lisa M Pasterk; Bernhard A Peskar; Rufina Schuligoi
Laropiprant attenuates EP3 and TP prostanoid receptor-mediated thrombus formation.
PloS one 2012;7(8):e40222.
2011: Petra Luschnig-Schratl; Gunther Marsche; Bernhard A Peskar; Sonia Philipose; Claudia Samberger; Rufina Schuligoi; Eva M Sturm; Eleonore Fröhlich; Stefan Gattenlöhner; Viktoria Konya; Doris Lang-Loidolt; Irmgard Th Lippe; Akos Heinemann
EP4 receptor stimulation down-regulates human eosinophil function.
Cellular and molecular life sciences : CMLS 2011;68(21):3573-87.
2011: Viktoria Konya; Gunther Marsche; Andrea Olschewski; Bernhard A Peskar; Sonia Philipose; Rudolf Schicho; Rufina Schuligoi; Eva M Sturm; Zoltán Bálint; Akos Heinemann
Interaction of eosinophils with endothelial cells is modulated by prostaglandin EP4 receptors.
European journal of immunology 2011;41(8):2379-89.
2010: Sonia Philipose; Viktoria Konya; Ivana Sreckovic; Gunther Marsche; Irmgard Th Lippe; Bernhard A Peskar; Akos Heinemann; Rufina Schuligoi
The prostaglandin E2 receptor EP4 is expressed by human platelets and potently inhibits platelet aggregation and thrombus formation.
Arteriosclerosis, thrombosis, and vascular biology 2010;30(12):2416-23.
2010: Viktoria Konya; Eva M Sturm; Petra Schratl; Eckhard Beubler; Gunther Marsche; Rufina Schuligoi; Irmgard Th Lippe; Bernhard A Peskar; Akos Heinemann
Endothelium-derived prostaglandin I(2) controls the migration of eosinophils.
The Journal of allergy and clinical immunology 2010;125(5):1105-13.
2010: Rufina Schuligoi; Eva M Sturm; Petra Luschnig; Viktoria Konya; Sonia Philipose; Miriam Sedej; Maria Waldhoer; Bernhard A Peskar; Akos Heinemann
CRTH2 and D-type prostanoid receptor antagonists as novel therapeutic agents for inflammatory diseases.
Pharmacology 2010;85(6):372-82.
2009: Brigitta M Peskar; Karlheinz Ehrlich; Rufina Schuligoi; Bernhard A Peskar
Role of lipoxygenases and lipoxin A(4)/annexin-1 receptor in gastric protection induced by 20% ethanol or sodium salicylate in rats.
Pharmacology 2009;84(5):310-3.
2009: Brigitta M Peskar; Karlheinz Ehrlich; Rufina Schuligoi; Bernhard A Peskar
Role of lipoxygenases and the lipoxin A(4)/annexin 1 receptor in ischemia-reperfusion-induced gastric mucosal damage in rats.
Pharmacology 2009;84(5):294-9.
2008: Eva M Sturm; Petra Schratl; Rufina Schuligoi; Viktoria Konya; Gunter J Sturm; Irmgard Th Lippe; Bernhard A Peskar; Akos Heinemann
Prostaglandin E2 inhibits eosinophil trafficking through E-prostanoid 2 receptors.
Journal of immunology (Baltimore, Md. : 1950) 2008;181(10):7273-83.
2008: Thomas Griesbacher; Irmgard Rainer; Beate Tiran; Bernhard A Peskar
Kallikrein inhibitors limit kinin B(2) antagonist-induced progression of oedematous to haemorrhagic pancreatitis in rats.
British journal of pharmacology 2008;155(6):865-74.
2008: Magdalena Grill; Akos Heinemann; Gerald Hoefler; Bernhard A Peskar; Rufina Schuligoi
Effect of endotoxin treatment on the expression and localization of spinal cyclooxygenase, prostaglandin synthases, and PGD2 receptors.
Journal of neurochemistry 2008;104(5):1345-57.
2008: Thomas Griesbacher; Veronika Pommer; Rufina Schuligoi; Beate Tiran; Bernhard A Peskar
Anti-inflammatory actions of perfluorooctanoic acid and peroxisome proliferator-activated receptors (PPAR) alpha and gamma in experimental acute pancreatitis.
International immunopharmacology 2008;8(2):325-9.
2008: C Prenn; Akos Heinemann; Rufina Schuligoi; Bernhard A Peskar
CRTH2 is not involved in the anti-enteropooling effect of PGD2 in the small intestine.
Pharmacology 2008;81(3):236-40.
2007: Julia F Royer; Petra Schratl; S Lorenz; Evi Kostenis; Trond Ulven; Rufina Schuligoi; Bernhard A Peskar; Akos Heinemann
A novel antagonist of CRTH2 blocks eosinophil release from bone marrow, chemotaxis and respiratory burst.
Allergy 2007;62(12):1401-9.
2007: Petra Schratl; Julia F Royer; Evi Kostenis; Trond Ulven; Eva M Sturm; Maria Waldhoer; Gerald Hoefler; Rufina Schuligoi; Irmgard Th Lippe; Bernhard A Peskar; Akos Heinemann
The role of the prostaglandin D2 receptor, DP, in eosinophil trafficking.
Journal of immunology (Baltimore, Md. : 1950) 2007;179(7):4792-9.
2007: Rufina Schuligoi; Ronald Schmidt; Gerd Geisslinger; Manfred Kollroser; Bernhard A Peskar; Akos Heinemann
PGD2 metabolism in plasma: kinetics and relationship with bioactivity on DP1 and CRTH2 receptors.
Biochemical pharmacology 2007;74(1):107-17.
2006: Petra Schratl; Eva M Sturm; Julia F Royer; Gunter J Sturm; Irmgard Th Lippe; Bernhard A Peskar; Akos Heinemann
Hierarchy of eosinophil chemoattractants: role of p38 mitogen-activated protein kinase.
European journal of immunology 2006;36(9):2401-9.
2006: Thomas Wultsch; Evelin Painsipp; Sabine Donner; Günther Sperk; Herbert Herzog; Bernhard A Peskar; Peter Holzer
Selective increase of dark phase water intake in neuropeptide-Y Y2 and Y4 receptor knockout mice.
Behavioural brain research 2006;168(2):255-60.
2006: Magdalena Grill; Bernhard A Peskar; Rufina Schuligoi; Rainer Amann
Systemic inflammation induces COX-2 mediated prostaglandin D2 biosynthesis in mice spinal cord.
Neuropharmacology 2006;50(2):165-73.
2005: Gunter J Sturm; Rufina Schuligoi; Eva M Sturm; Julia F Royer; Doris Lang-Loidolt; Heinz Stammberger; Rainer Amann; Bernhard A Peskar; Akos Heinemann
5-Oxo-6,8,11,14-eicosatetraenoic acid is a potent chemoattractant for human basophils.
The Journal of allergy and clinical immunology 2005;116(5):1014-9.
2005: Akos Heinemann; Gunter J Sturm; Martina Ofner; Eva M Sturm; Charlotte L Weller; Bernhard A Peskar; Adele Hartnell
Stem cell factor stimulates the chemotaxis, integrin upregulation, and survival of human basophils.
The Journal of allergy and clinical immunology 2005;116(4):820-6.
2005: Rufina Schuligoi; Magdalena Grill; Akos Heinemann; Bernhard A Peskar; Rainer Amann
Sequential induction of prostaglandin E and D synthases in inflammation.
Biochemical and biophysical research communications 2005;335(3):684-9.
2004: Rosemarie A Reiter; Bernhard A Peskar; Helmut Sinzinger
Defects in the prostaglandin system--what is known?
Prostaglandins, leukotrienes, and essential fatty acids 2004;71(5):347-50.
2004: Ruth Ulcar; Bernhard A Peskar; Rufina Schuligoi; Akos Heinemann; Harald H Kessler; Brigitte I Santner; Rainer Amann
Cyclooxygenase inhibition in human monocytes increases endotoxin-induced TNF alpha without affecting cyclooxygenase-2 expression.
European journal of pharmacology 2004;501(1-3):9-17.
2004: Eva Böhm; Gunter J Sturm; Iris Weiglhofer; Hilary Sandig; Michitaka Shichijo; Anne McNamee; James E Pease; Manfred Kollroser; Bernhard A Peskar; Akos Heinemann
11-Dehydro-thromboxane B2, a stable thromboxane metabolite, is a full agonist of chemoattractant receptor-homologous molecule expressed on TH2 cells (CRTH2) in human eosinophils and basophils.
The Journal of biological chemistry 2004;279(9):7663-70.
2003: Brigitta M Peskar; Nadia Sawka; Karlheinz Ehrlich; Bernhard A Peskar
Role of cyclooxygenase-1 and -2, phospholipase C, and protein kinase C in prostaglandin-mediated gastroprotection.
The Journal of pharmacology and experimental therapeutics 2003;305(3):1233-8.
2003: Thomas Griesbacher; Irmgard Rainer; Beate Tiran; Edwin Fink; Fred Lembeck; Bernhard A Peskar
Mechanism of kinin release during experimental acute pancreatitis in rats: evidence for pro- as well as anti-inflammatory roles of oedema formation.
British journal of pharmacology 2003;139(2):299-308.
2003: Akos Heinemann; Rufina Schuligoi; Ian Sabroe; Adele Hartnell; Bernhard A Peskar
Delta 12-prostaglandin J2, a plasma metabolite of prostaglandin D2, causes eosinophil mobilization from the bone marrow and primes eosinophils for chemotaxis.
Journal of immunology (Baltimore, Md. : 1950) 2003;170(9):4752-8.
2003: Rufina Schuligoi; Ruth Ulcar; Bernhard A Peskar; Rainer Amann
Effect of endotoxin treatment on the expression of cyclooxygenase-2 and prostaglandin synthases in spinal cord, dorsal root ganglia, and skin of rats.
Neuroscience 2003;116(4):1043-52.
2003: Akos Heinemann; Martina Ofner; Rainer Amann; Bernhard A Peskar
A novel assay to measure the calcium flux in human basophils: effects of chemokines and nerve growth factor.
Pharmacology 2003;67(1):49-54.
2002: Anaid Shahbazian; Akos Heinemann; Bernhard A Peskar; Peter Holzer
Differential peristaltic motor effects of prostanoid (DP, EP, IP, TP) and leukotriene receptor agonists in the guinea-pig isolated small intestine.
British journal of pharmacology 2002;137(7):1047-54.
2002: Ivo Juránek; Viktor Bauer; Josef Donnerer; Fred Lembeck; Bernhard A Peskar
Severe hypoxia inhibits prostaglandin I(2) biosynthesis and vasodilatory responses induced by ionophore A23187 in the isolated rabbit ear.
Pharmacology 2002;66(4):199-205.
2002: Helmut Sinzinger; Roswitha Wolfram; Bernhard A Peskar
Muscular side effects of statins.
Journal of cardiovascular pharmacology 2002;40(2):163-71.
2002: Victoria E L Stubbs; Petra Schratl; Adele Hartnell; Timothy J Williams; Bernhard A Peskar; Akos Heinemann; Ian Sabroe
Indomethacin causes prostaglandin D(2)-like and eotaxin-like selective responses in eosinophils and basophils.
The Journal of biological chemistry 2002;277(29):26012-20.
2002: Rainer Amann; Bernhard A Peskar
Anti-inflammatory effects of aspirin and sodium salicylate.
European journal of pharmacology 2002;447(1):1-9.
2002: Brigitta M Peskar; Karlheinz Ehrlich; Bernhard A Peskar
Role of ATP-sensitive potassium channels in prostaglandin-mediated gastroprotection in the rat.
The Journal of pharmacology and experimental therapeutics 2002;301(3):969-74.
2002: Brigitta M Peskar; Karlheinz Ehrlich; Bernhard A Peskar
Interaction of cyclooxygenase-2 inhibitors and salicylate in gastric mucosal damage.
European journal of pharmacology 2002;434(1-2):65-70.
2002: Sabine Küsters; Rufina Schuligoi; Karl-Bernd Hüttenbrink; Jutta Rudert; Angela Wachs; Istvan Szelenyi; Bernhard A Peskar
Effects of antihistamines on leukotriene and cytokine release from dispersed nasal polyp cells.
Arzneimittel-Forschung 2002;52(2):97-102.
2001: Rainer Amann; Tamara Egger; Rufina Schuligoi; Akos Heinemann; Bernhard A Peskar
Sodium salicylate enhances the expression of cyclooxygenase-2 in endotoxin-stimulated human mononuclear cells.
European journal of pharmacology 2001;433(1):129-34.
2001: Eckhard Beubler; Rufina Schuligoi; Ashok K Chopra; Deborah A Ribardo; Bernhard A Peskar
Cholera toxin induces prostaglandin synthesis via post-transcriptional activation of cyclooxygenase-2 in the rat jejunum.
The Journal of pharmacology and experimental therapeutics 2001;297(3):940-5.
2001: Rainer Amann; Bernhard A Peskar; Rufina Schuligoi
Effects of terbutaline on NGF formation in allergic inflammation of the rat.
British journal of pharmacology 2001;133(1):186-92.
2001: Anaid Shahbazian; Rufina Schuligoi; Akos Heinemann; Bernhard A Peskar; Peter Holzer
Disturbance of peristalsis in the guinea-pig isolated small intestine by indomethacin, but not cyclo-oxygenase isoform-selective inhibitors.
British journal of pharmacology 2001;132(6):1299-309.
2001: M Sommerauer; M Ates; Hans Gühring; Kay Brune; Rainer Amann; Bernhard A Peskar
Ketoprofen-induced cyclooxygenase inhibition in renal medulla and platelets of rats treated with caffeine.
Pharmacology 2001;63(4):234-9.
2001: Rainer Amann; Rufina Schuligoi; Bernhard A Peskar
Effects of COX-1 and COX-2 inhibitors on eicosanoid biosynthesis and the release of substance P from the guinea-pig isolated perfused lung.
Inflammation research : official journal of the European Histamine Research Society ... [et al.] 2001;50(1):50-3.
1999: Rainer Amann; Rufina Schuligoi; Bernhard A Peskar
Eicosanoid release in the endotoxin-primed isolated perfused rat lung and its pharmacological modification.
Inflammation research : official journal of the European Histamine Research Society ... [et al.] 1999;48(12):632-6.
1998: Akos Heinemann; G Horina; Rudolf E Stauber; Christof Pertl; Peter Holzer; Bernhard A Peskar
Lack of effect of a selective vasopressin V1A receptor antagonist SR 49,059, on potentiation by vasopressin of adrenoceptor-mediated pressor responses in the rat mesenteric arterial bed.
British journal of pharmacology 1998;125(6):1120-7.
1998: Rufina Schuligoi; Bernhard A Peskar; Josef Donnerer; Rainer Amann
Bradykinin-evoked sensitization of neuropeptide release from afferent neurons in the guinea-pig lung.
British journal of pharmacology 1998;125(2):388-92.
1998: Roland E Willburger; Ralf Hermann Wittenberg; K Schmidt; K S Kleemeyer; Bernhard A Peskar
Antiinflammatory effect of tepoxalin: blood and synovial tissue studied in patients with knee arthrosis.
Acta orthopaedica Scandinavica 1998;69(3):295-300.
1998: Rufina Schuligoi; Rainer Amann; C Prenn; Bernhard A Peskar
Effects of the cyclooxygenase-2 inhibitor NS-398 on thromboxane and leukotriene synthesis in rat peritoneal cells.
Inflammation research : official journal of the European Histamine Research Society ... [et al.] 1998;47(5):227-30.
1997: Akos Heinemann; CH Wachter; Bernhard A Peskar; Peter Holzer
Dilatation by angiotensin II of the rat femoral arterial bed in vivo via pressure/flow-induced release of nitric oxide and prostaglandins.
British journal of pharmacology 1997;122(6):975-84.
1997: Rufina Schuligoi; R Amann; P Angelberger; Bernhard A Peskar
Determination of nociceptin-like immunoreactivity in the rat dorsal spinal cord.
Neuroscience letters 1997;224(2):136-8.
1997: Rufina Schuligoi; Rainer Amann; Josef Donnerer; Bernhard A Peskar
Release of calcitonin gene-related peptide in cardiac anaphylaxis.
Naunyn-Schmiedeberg's archives of pharmacology 1997;355(2):224-9.
1996: Roland E Willburger; Ralf Hermann Wittenberg; K S Kleemeyer; R Hoos; F L Brunner-Ferber; Bernhard A Peskar
Inhibition of eicosanoid release from synovial organ culture by incubation with tepoxalin and its acid metabolite.
Prostaglandins 1996;52(4):327-38.
1996: Gerd Geisslinger; Bernhard A Peskar; D Pallapies; R Sittl; Micha Levy; Kay Brune
The effects on platelet aggregation and prostanoid biosynthesis of two parenteral analgesics: ketorolac tromethamine and dipyrone.
Thrombosis and haemostasis 1996;76(4):592-7.
1996: Rainer Amann; Rufina Schuligoi; I Lanz; Bernhard A Peskar
Effect of a 5-lipoxygenase inhibitor on nerve growth factor-induced thermal hyperalgesia in the rat.
European journal of pharmacology 1996;306(1-3):89-91.
1996: D Pallapies; A Muhs; L Bertram; G Rohleder; P Nagyiványi; Bernhard A Peskar
Effects of single oral doses of lysine clonixinate and acetylsalicylic acid on platelet functions in man.
European journal of clinical pharmacology 1996;49(5):351-4.
1995: Peter Holzer; Milana Jocic; Bernhard A Peskar
Mediation by prostaglandins of the nitric oxide-induced neurogenic vasodilatation in rat skin.
British journal of pharmacology 1995;116(5):2365-70.
1995: D Pallapies; Bernhard A Peskar; Brigitta M Peskar
Interaction of 5-aminosalicylic acid with nitric oxide on rat aortic strips and human platelets.
European journal of pharmacology 1995;282(1-3):145-9.
1995: D Pallapies; A Salinger; A Meyer zum Gottesberge; D J Atkins; G Rohleder; P Nagyiványi; Bernhard A Peskar
Effects of lysine clonixinate and ketorolac tromethamine on prostanoid release from various rat organs incubated ex vivo.
Life sciences 1995;57(2):83-9.
1994: D Pallapies; Bernhard A Peskar; Kay Brune; H U Zeilhofer
Modulation of nitric oxide effects by flurbiprofen enantiomers and nefopam and its relation to antinociception.
European journal of pharmacology 1994;271(2-3):335-40.
1994: D Pallapies; Bernhard A Peskar; Kay Brune; Gerd Geisslinger
Effects on platelet functions and pharmacokinetics of azapropazone and ketorolac tromethamine given as single parenteral doses.
British journal of clinical pharmacology 1994;37(4):335-9.
1993: K Brune; D Bickel; Bernhard A Peskar
Gastro-protective effects by extracts of Petasites hybridus: the role of inhibition of peptido-leukotriene synthesis.
Planta medica 1993;59(6):494-6.
1993: Ralf Hermann Wittenberg; Roland E Willburger; K S Kleemeyer; Bernhard A Peskar
In vitro release of prostaglandins and leukotrienes from synovial tissue, cartilage, and bone in degenerative joint diseases.
Arthritis and rheumatism 1993;36(10):1444-50.
1993: D Pallapies; Bernhard A Peskar
Effect of prostaglandin (PG) E1 and its initial metabolites on neutrophil-induced inhibition of human platelet aggregation.
Thrombosis research 1993;71(3):217-25.
1993: James A Orr; H Shams; W Karla; Bernhard A Peskar; Peter Scheid
Transient ventilatory responses to endotoxin infusion in the cat are mediated by thromboxane A2.
Respiration physiology 1993;93(2):189-201.
1993: D Pallapies; Bernhard A Peskar
13,14-Dihydro-prostaglandin E1 in atherosclerosis.
Seminars in thrombosis and hemostasis 1993;19(2):144-8.
1992: D Pallapies; Kay-Uwe Jirmann; J Rademann; Thomas Simmet; J Rutowski; A Dembińska-Kieć; Bernhard A Peskar
Effect of prostaglandin E2 and 3-morpholinosydnonimine (SIN-1) on arachidonic acid metabolism in fMLP-stimulated rat neutrophils and on thrombin-induced human platelet aggregation.
Agents and actions 1992;36(1-2):77-82.
1992: Thomas Simmet; S Pritze; K I Thelen; Bernhard A Peskar
Release of endothelin in the oleic acid-induced respiratory distress syndrome in rats.
European journal of pharmacology 1992;211(3):319-22.
1992: D Pallapies; K Thelen; A Dembińska-Kieć; Thomas Simmet; Bernhard A Peskar
Effect of 3-morpholinosydnonimine (SIN-1), NG-nitro-L-arginine (NNA) and NG-monomethyl-L-arginine (NMMA) on isolated anaphylactic guinea-pig hearts.
Agents and actions. Supplements 1992;37():114-9.
1992: S Pritze; Bernhard A Peskar; Thomas Simmet
Release of eicosanoids and endothelin in an experimental model of adult respiratory distress syndrome.
Agents and actions. Supplements 1992;37():41-6.
1992: K I Thelen; A Dembinska-Kiéc; D Pallapies; Thomas Simmet; Bernhard A Peskar
Effect of 3-morpholinosydnonimine (SIN-1) and NG-nitro-L-arginine (NNA) on isolated perfused anaphylactic guinea-pig hearts.
Naunyn-Schmiedeberg's archives of pharmacology 1992;345(1):93-9.
1991: Brigitta M Peskar; S Kluge; Bernhard A Peskar; S M Soglowek; Kay Brune
Effects of pure enantiomers of flurbiprofen in comparison to racemic flurbiprofen on eicosanoid release from various rat organs ex vivo.
Prostaglandins 1991;42(6):515-31.
1991: A Dembinska-Kiec; D Pallapies; Thomas Simmet; Brigitta M Peskar; Bernhard A Peskar
Effect of carbenoxolone on the biological activity of nitric oxide: relation to gastroprotection.
British journal of pharmacology 1991;104(4):811-6.
1991: S Pritze; Thomas Simmet; Bernhard A Peskar
Effect of platelet-activating factor on porcine pulmonary blood vessels in vitro.
Naunyn-Schmiedeberg's archives of pharmacology 1991;344(4):495-9.
1991: Bernhard A Peskar; W Cawello; W Rogatti; G Rudofsky
On the metabolism of prostaglandin E1 administered intravenously to human volunteers.
Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 1991;42(3):327-31.
1991: M Trautmann; Brigitta M Peskar; Bernhard A Peskar
Aspirin-like drugs, ethanol-induced rat gastric injury and mucosal eicosanoid release.
European journal of pharmacology 1991;201(1):53-8.
1991: Brigitta M Peskar; M Trautmann; P Nowak; Bernhard A Peskar
Release of 15-hydroxy-5,8,11,13-eicosatetraenoic acid and cysteinyl-leukotrienes in carrageenin-induced inflammation: effect of non-steroidal anti-inflammatory drugs.
Agents and actions 1991;33(3-4):240-6.
1991: Brigitta M Peskar; Michael Respondek; K M Müller; Bernhard A Peskar
A role for nitric oxide in capsaicin-induced gastroprotection.
European journal of pharmacology 1991;198(1):113-4.
1991: Bernhard A Peskar; W H Hesse; W Rogatti; C Diehm; G Rudofsky; H Schweer; H W Seyberth
Formation of 13,14-dihydro-prostaglandin E1 during intravenous infusions of prostaglandin E1 in patients with peripheral arterial occlusive disease.
Prostaglandins 1991;41(3):225-8.
1991: Peter Holzer; I I Lippe; H E Raybould; M A Pabst; E H Livingston; Rainer Amann; B M Peskar; Bernhard A Peskar; Y Taché; P H Guth
Role of peptidergic sensory neurons in gastric mucosal blood flow and protection.
Annals of the New York Academy of Sciences 1991;632():272-82.
1991: D Pallapies; Bernhard A Peskar
Substances with vasoactive effects mediated by the prostaglandin system.
VASA. Supplementum 1991;33():75-6.
1991: W H Hesse; G Rudofsky; Bernhard A Peskar
[Metabolism of intravenously administered prostaglandin E1 in patients with peripheral arterial occlusive disease].
Wiener klinische Wochenschrift 1991;103(18):554-7.
1991: H R Wittenberg; K Kleemeyer; Brigitta M Peskar; Bernhard A Peskar
[Effect of sulfasalazine and its metabolites on prostaglandin and leukotriene liberation from human synovial tissue].
Wiener klinische Wochenschrift 1991;103(2):34-9.
1990: W H Hesse; H Schweer; H W Seyberth; Bernhard A Peskar
Separation and determination of prostaglandin E1 metabolites by high-performance liquid chromatography.
Journal of chromatography 1990;533():159-65.
1990: Thomas Simmet; W Luck; Michael Winking; W K Delank; Bernhard A Peskar
Identification and characterization of cysteinyl-leukotriene formation in tissue slices from human intracranial tumors: evidence for their biosynthesis under in vivo conditions.
Journal of neurochemistry 1990;54(6):2091-9.
1990: P Holzer; Brigitta M Peskar; Bernhard A Peskar; R Amann
Release of calcitonin gene-related peptide induced by capsaicin in the vascularly perfused rat stomach.
Neuroscience letters 1990;108(1-2):195-200.
1989: A Dembinska-Kiec; P Novak; Brigitta M Peskar; Bernhard A Peskar
Release of cysteinyl leukotrienes is of minor importance in platelet-activating factor-induced reduction of perfusion rate in the rat gastric vascular bed.
Progress in clinical and biological research 1989;301():487-91.
1989: S Pritze; Thomas Simmet; Bernhard A Peskar
Effect of platelet-activating factor (PAF) on porcine pulmonary vessels in vitro.
Progress in clinical and biological research 1989;301():481-5.
1989: Thomas Simmet; W Luck; W K Delank; Bernhard A Peskar
Biosynthesis of cysteinyl-leukotrienes by human brain tissue in vitro.
Advances in prostaglandin, thromboxane, and leukotriene research 1989;19():402-6.
1989: W Luck; Thomas Simmet; Ernst-Wilhelm Schmidt; Bernhard A Peskar
Formation of cysteinyl-leukotrienes by human bronchial mucosa in chronic obstructive bronchitis.
Progress in clinical and biological research 1989;301():259-65.
1988: Thomas Simmet; Bernhard A Peskar
Prostaglandin E1 and arterial occlusive disease: pharmacological considerations.
European journal of clinical investigation 1988;18(6):549-54.
1988: G Wittmann; P Weinerowski; Thomas Simmet; Bernhard A Peskar
Effect of muscarinic receptor stimulation on release of cysteinyl-leukotrienes and thromboxane B2 from anaphylactic guinea-pig hearts.
Naunyn-Schmiedeberg's archives of pharmacology 1988;338(5):577-81.
1988: Thomas Simmet; W Luck; W K Delank; Bernhard A Peskar
Formation of cysteinyl-leukotrienes by human brain tissue.
Brain research 1988;456(2):344-9.
1988: P Fitscha; Thomas Simmet; Bernhard A Peskar; H Reuter; H Sinzinger; W Rogatti; V Tilsner
[Fibrinolytic activity, thrombocyte function and pharmacokinetics during intra-arterial or intravenous prostaglandin E1 infusion in patients with chronic arterial occlusive disease].
Wiener klinische Wochenschrift 1988;100(14):477-81.
1988: U Achterrath-Tuckermann; Thomas Simmet; W Luck; I Szelenyi; Bernhard A Peskar
Inhibition of cysteinyl-leukotriene production by azelastine and its biological significance.
Agents and actions 1988;24(3-4):217-23.
1988: Brigitta M Peskar; U Hoppe; K Lange; Bernhard A Peskar
Effects of non-steroidal anti-inflammatory drugs on rat gastric mucosal leukotriene C4 and prostanoid release: relation to ethanol-induced injury.
British journal of pharmacology 1988;93(4):937-43.
1988: H Shams; Bernhard A Peskar; Peter Scheid
Acid infusion elicits thromboxane A2-mediated effects on respiration and pulmonary hemodynamics in the cat.
Respiration physiology 1988;71(2):169-83.
1987: Thomas Simmet; J Aissa; D Sutter; Heinz Juan; Bernhard A Peskar
Modulation of the contractile activity of the guinea-pig lung parenchymal strip by exogenous 5,8,11,14,17-eicosapentaenoic acid.
Naunyn-Schmiedeberg's archives of pharmacology 1987;335(6):652-9.
1987: G Wittmann; B M Peskar; M Edelmann; K M Müller; Thomas Simmet; Bernhard A Peskar
Formation of cysteinyl-containing leukotrienes by human arterial tissues.
Prostaglandins 1987;33(4):591-8.
1987: Thomas Simmet; P Fitscha; Bernhard A Peskar; H Sinzinger; W Rogatti; V Tilsner
Studies on pharmacokinetics, platelet function and fibrinolytic activity under various prostaglandin E1 infusion regimens.
Progress in clinical and biological research 1987;242():365-73.
1987: K Lange; Bernhard A Peskar; Brigitta M Peskar
Inhibition of leukotriene formation as a mode of action of gastroprotective drugs.
Progress in clinical and biological research 1987;242():283-8.
1987: H R Wittenberg; K Kleemeyer; U Hoppe; Brigitta M Peskar; Bernhard A Peskar
Release of eicosanoids from human synovial tissue and the effect of anti-inflammatory drugs.
Progress in clinical and biological research 1987;242():277-82.
1987: K Lange; Bernhard A Peskar; Brigitta M Peskar
Stimulation of rat gastric mucosal leukotriene C4 formation by ethanol and effect of gastric protective drugs.
Advances in prostaglandin, thromboxane, and leukotriene research 1987;17A():299-302.
1987: K W Dreyling; U Hoppe; Bernhard A Peskar; K Schaarschmidt; Brigitta M Peskar
Leukotrienes in Crohn's disease: effect of sulfasalazine and 5-aminosalicylic acid.
Advances in prostaglandin, thromboxane, and leukotriene research 1987;17A():339-43.
1987: Thomas Simmet; Heinz Juan; Bernhard A Peskar
Modulation of the anaphylactic reaction in sensitized guinea-pig hearts by timnodonic acid.
Progress in clinical and biological research 1987;242():63-9.
1987: Thomas Simmet; J Aissa; D Sutter; Heinz Juan; Bernhard A Peskar
Modulation of the contractile activity of the guinea-pig lung parenchymal strip by timnodonic acid.
Progress in clinical and biological research 1987;242():375-80.
1987: U Hoppe; Brigitta M Peskar; Bernhard A Peskar
Radioimmunoassay for leukotriene E4.
Progress in clinical and biological research 1987;242():299-302.
1986: K W Dreyling; U Hoppe; Bernhard A Peskar; K Morgenroth; W Kozuschek; Brigitta M Peskar
Leukotriene synthesis by human gastrointestinal tissues.
Biochimica et biophysica acta 1986;878(2):184-93.
1986: Brigitta M Peskar; K W Dreyling; Bernhard A Peskar; Burkard May; H Goebell
Enhanced formation of sulfidopeptide-leukotrienes in ulcerative colitis and Crohn's disease: inhibition by sulfasalazine and 5-aminosalicylic acid.
Agents and actions 1986;18(3-4):381-3.
1986: Brigitta M Peskar; W Kozuschek; K Morgenroth; U Hoppe; K W Dreyling; Bernhard A Peskar
[Leukotriene synthesis by gastrointestinal tissue and its pharmacologic modification].
Wiener klinische Wochenschrift 1986;98(4):98-104.
1986: C Coersmeier; H R Wittenberg; U Aehringhaus; K W Dreyling; Brigitta M Peskar; K Brune; Bernhard A Peskar
Effect of anti-inflammatory and analgesic pyrazoles on arachidonic acid metabolism in isolated heart and gastric mucosa preparations.
Agents and actions. Supplements 1986;19():137-54.
1985: P Weinerowski; G Wittmann; U Aehringhaus; Bernhard A Peskar
Pharmacological modification of leukotriene release and coronary constrictor effect in cardiac anaphylaxis.
Advances in prostaglandin, thromboxane, and leukotriene research 1985;13():47-50.
1984: U Aehringhaus; H Weiler; Bernhard A Peskar; Brigitta M Peskar
Molecular mechanisms of the gastric toxicity of antirheumatic drugs.
Archives of toxicology. Supplement. = Archiv für Toxikologie. Supplement 1984;7():323-7.
1983: U Aehringhaus; Bernhard A Peskar; H R Wittenberg; R H Wölbling
Effect of inhibition of synthesis and receptor antagonism of SRS-A in cardiac anaphylaxis.
British journal of pharmacology 1983;80(1):73-80.
1983: R H Wölbling; U Aehringhaus; Brigitta M Peskar; Bernhard A Peskar
Release of slow-reacting substance of anaphylaxis from layers of guinea pig aorta.
Prostaglandins 1983;25(6):823-8.
1983: R H Wölbling; U Aehringhaus; Bernhard A Peskar; K Morgenroth; Brigitta M Peskar
Release of slow-reacting substance of anaphylaxis and leukotriene C4-like immunoreactivity from guinea pig colonic tissue.
Prostaglandins 1983;25(6):809-22.
1982: U Aehringhaus; R H Wölbling; W König; C Patrono; Brigitta M Peskar; Bernhard A Peskar
Release of leukotriene C4 from human polymorphonuclear leucocytes as determined by radioimmunoassay.
FEBS letters 1982;146(1):111-4.